Literature DB >> 15518825

Comprehensive sequence analysis of the E1A proteins of human and simian adenoviruses.

N Avvakumov1, A E Kajon, R C Hoeben, J S Mymryk.   

Abstract

Despite extensive study of human adenovirus type 5 E1A, surprisingly little is known about the E1A proteins of other adenoviruses. We report here a comprehensive analysis of the sequences of 34 E1A proteins. These represent all six primate adenovirus subgroups and include all human representatives of subgroups A, C, E, and F, eight from subgroup B, nine from subgroup D, and seven simian adenovirus E1A sequences. We observed that many, but not all, functional domains identified in human adenovirus type 5 E1A are recognizably present in the other E1A proteins. Importantly, we identified highly conserved sequences without known activities or binding partners, suggesting that previously unrecognized determinants of E1A function remain to be uncovered. Overall, our analysis forms a solid foundation for future study of the activities and features of the E1A proteins of different serotypes and identifies new avenues for investigating E1A function.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15518825     DOI: 10.1016/j.virol.2004.08.007

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  29 in total

1.  The Cellular Protein Complex Associated with a Transforming Region of E1A Contains c-MYC.

Authors:  S Vijayalingam; T Subramanian; Ling-Jun Zhao; G Chinnadurai
Journal:  J Virol       Date:  2015-11-11       Impact factor: 5.103

2.  Structure of the retinoblastoma protein bound to adenovirus E1A reveals the molecular basis for viral oncoprotein inactivation of a tumor suppressor.

Authors:  Xin Liu; Ronen Marmorstein
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

3.  pRB-E2F1 complexes are resistant to adenovirus E1A-mediated disruption.

Authors:  L A Seifried; S Talluri; M Cecchini; L M Julian; J S Mymryk; F A Dick
Journal:  J Virol       Date:  2008-02-27       Impact factor: 5.103

4.  p400 function is required for the adenovirus E1A-mediated suppression of EGFR and tumour cell killing.

Authors:  M B Flinterman; J S Mymryk; P Klanrit; A F Yousef; S W Lowe; C Caldas; J Gäken; F Farzaneh; M Tavassoli
Journal:  Oncogene       Date:  2007-05-07       Impact factor: 9.867

5.  Genomic characterization of human adenovirus type 4 strains isolated worldwide since 1953 identifies two separable phylogroups evolving at different rates from their most recent common ancestor.

Authors:  Gabriel Gonzalez; Camden R Bair; Daryl M Lamson; Hidemi Watanabe; Laura Panto; Michael J Carr; Adriana E Kajon
Journal:  Virology       Date:  2019-09-08       Impact factor: 3.616

Review 6.  Intrinsic structural disorder in adenovirus E1A: a viral molecular hub linking multiple diverse processes.

Authors:  Peter Pelka; Jailal N G Ablack; Gregory J Fonseca; Ahmed F Yousef; Joe S Mymryk
Journal:  J Virol       Date:  2008-04-02       Impact factor: 5.103

7.  Adenovirus E1A directly targets the E2F/DP-1 complex.

Authors:  Peter Pelka; Matthew S Miller; Matthew Cecchini; Ahmed F Yousef; Dawn M Bowdish; Fred Dick; Peter Whyte; Joe S Mymryk
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

8.  Mimicry of Cellular A Kinase-Anchoring Proteins Is a Conserved and Critical Function of E1A across Various Human Adenovirus Species.

Authors:  Cason R King; Steven F Gameiro; Tanner M Tessier; Ali Zhang; Joe S Mymryk
Journal:  J Virol       Date:  2018-03-28       Impact factor: 5.103

9.  Mapping the interactions of adenoviral E1A proteins with the p160 nuclear receptor coactivator binding domain of CBP.

Authors:  Peter Haberz; Munehito Arai; Maria A Martinez-Yamout; H Jane Dyson; Peter E Wright
Journal:  Protein Sci       Date:  2016-10-15       Impact factor: 6.725

10.  Adenovirus type 5 E1A and E6 proteins of low-risk cutaneous beta-human papillomaviruses suppress cell transformation through interaction with FOXK1/K2 transcription factors.

Authors:  Jessica Komorek; Mohan Kuppuswamy; T Subramanian; S Vijayalingam; Elena Lomonosova; Ling-Jun Zhao; Joe S Mymryk; Kimberly Schmitt; G Chinnadurai
Journal:  J Virol       Date:  2010-01-06       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.